PLTMax® used with MSCs in positive Phase I trial!

Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease

Jul 01 2017

Click for the article featured in the July 2017 issue of Gastroenterology.

 

PLTMax® used in culture of MSCs in a bioabsorbable matrix, for treatment of Perianal Fistulas in patients with Crohn's Disease.

• Prev
• Efficient Large-Scale Expansion of MSCs for Translational Medicine and Research Use